Treating very-long coronary artery disease in the contemporary drug eluting stent era: Single long 48 mm stent versus two overlapping stents showed comparable clinical outcomes.

[1]  A. Lansky,et al.  Clinical outcomes after PCI treatment of very long lesions with the XIENCE V everolimus eluting stent; Pooled analysis from the SPIRIT and XIENCE V USA prospective multicenter trials , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  M. Nishino,et al.  Comparison of Angiographic and 1-Year Outcomes Between a Long Single Stent and Overlapping Double Stents in Patients With Newer-Generation Drug-Eluting Stents for Long Narrowings. , 2016, The American journal of cardiology.

[3]  L. Räber,et al.  Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[4]  I. Barbash,et al.  Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents. , 2013, The American journal of cardiology.

[5]  A. Yeung,et al.  Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program , 2013, Heart.

[6]  P. Serruys,et al.  Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  Samin K. Sharma,et al.  Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials. , 2011, Journal of the American College of Cardiology.

[8]  P. Serruys,et al.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial , 2011, European heart journal.

[9]  Seung‐Jung Park,et al.  The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. , 2010, JACC. Cardiovascular interventions.

[10]  F. Eberli,et al.  Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. , 2010, Journal of the American College of Cardiology.

[11]  Y. Jang,et al.  Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography , 2010, The International Journal of Cardiovascular Imaging.

[12]  G. Stone,et al.  Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. , 2009, The American journal of cardiology.

[13]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[14]  Hong Wang,et al.  Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. , 2006, Journal of the American College of Cardiology.

[15]  J. Popma,et al.  Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial: Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice , 2005, Circulation.

[16]  P. Serruys,et al.  "Full metal jacket" (stented length > or =64 mm) using drug-eluting stents for de novo coronary artery lesions. , 2005, American heart journal.

[17]  Gregg W Stone,et al.  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. , 2005, JAMA.

[18]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  R. Virmani,et al.  Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents , 2005, Circulation.

[20]  I. Iakovou,et al.  Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. , 2005, Journal of the American College of Cardiology.

[21]  I. Iakovou,et al.  Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.

[22]  P. Serruys,et al.  Very long sirolimus-eluting stent implantation for de novo coronary lesions. , 2004, The American journal of cardiology.

[23]  S. Silber,et al.  Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings. , 2002, The American journal of cardiology.